Biofrontera AG
BFFTF
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.91M
Close$
Share Statistics
| Market cap | $1.91 Million |
|---|---|
| Enterprise Value | $4.75 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-13.02 |
| Beta | 0.59 |
| Outstanding Shares | 5,773,993 |
Return
| Return on Equity | -106.87% |
|---|---|
| Return on Assets | -26.45% |
| Return on Invested Capital | -50.93% |
Valuation & Multiples
| P/E Ratio | -1.62 |
|---|---|
| PEG | 1.82 |
| Price to Sales | 0.05 |
| Price to Book Ratio | 0.33 |
| Enterprise Value to Revenue | 0.1 |
| Enterprise Value to EBIT | -0.69 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.58 |
| Debt to Equity | 1.26 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Biofrontera Inc
82 employees
CEO: Hermann Lübbert Biofrontera AG, a biopharmaceutical company, engages in the research, development, and distribution of dermatological products in Germany, Spain, the United Kingdom, rest of Europe, the United States, and internationally. The company off...